Alternatives to Galimedix Therapeutics
Galimedix Therapeutics is a Life Sciences tool: galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
Galimedix Therapeutics profileMore Life Sciences alternatives
The 20 closest Life Sciences companies to Galimedix Therapeutics
- Website
GE HealthCare21MedTechChicago, United StatesA global medical technology, diagnostics, and digital solutions innovator, providing integrated solutions for precision health.
- Website
Upstream Bio61Life SciencesWaltham, United States$400.0MClinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
- Website AYAyala Pharmaceuticals41Life SciencesJerusalem, Israel$72.0M
Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.
- Website
Impact Biotech39Life SciencesTel Aviv, Israel$2.7MDevelops and launches Padeliporfin VTP therapy for solid tumor treatment.
- Website
Somite.ai63Life SciencesTel Aviv, Israel$57.1MAI-driven digital twin of embryo development for cell-based therapies.
- Website
Ella Therapeutics47Life SciencesBoston, United StatesDeveloping microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.
- Website
Immunyx Pharma46Life SciencesNew York, United StatesBiopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.
- Website
Mana.bio59Life SciencesBoston, United States$19.5MAI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
- Website
QuantHealth57Life SciencesTel Aviv, Israel$64.6MAI-powered patient-centric drug simulations to accelerate and de-risk drug development.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
PhaseV56Life SciencesTel Aviv, Israel$65.0MDevelops a platform for adaptive clinical trial design and closed-loop execution.
- Website
UB Therapeutics40Life SciencesCambridge, United StatesBiotechnology company developing novel therapies for multiple myeloma.
- Website
Curesponse55Life SciencesTel Aviv, Israel$28.0MPersonalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.
- Website
Omnix Medical54Life SciencesTel Aviv, Israel$25.0MOmnix Medical is developing a novel platform for advanced wound care management.
- Website
Aummune53Life SciencesSan Diego, United States$10.0MDevelops a platform for individual drug customization using aptamers for cancer treatment.
- Website
EviCure37Life SciencesSan Diego, United StatesDeveloping exosome-based cancer therapeutics using AI and novel human cancer models.
- Website
Eximore52Life SciencesTel Aviv, Israel$10.0MBiopharmaceutical company developing innovative punctal plug technology for eye disease therapies.
- Website
ZipBio52Life SciencesCambridge, United States$4.0MCompressing biology to develop the next generation of therapies.
- Website
Gamida Cell51Life SciencesBoston, United States$297.3MBiotechnology company developing potentially curative cell therapies for cancer patients.
- Website
Nectin Therapeutics50Life Sciences$64.1MBiotech company developing next-generation immunotherapy agents to unlock the immune system.
Showing the 20 closest matches. See the rest on the Galimedix Therapeutics profile.
Compare Galimedix Therapeutics head to head
Side by side on what each one does, what it costs, and what real users report.